Brynne Potter

Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA.

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

Sloan Financial Group, Inc. provides financial advisory services. The private company is based in Durham, NC. The CEO of the company is Maceo Kennedy Sloan.

Southeast Interactive Technology Funds (Southeast Interactive Technology) is a venture capital firm founded in 1995 by David Blivin. The firm is headquartered in Morrisville, North Carolina.

Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA.

Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA.

Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ.

Part of Orchestra Biomed Holdings, Inc., FreeHold Surgical LLC is a company that specializes in surgical retractors. The company is based in New Hope, PA. The company's retractors are the only fully and continuously adjustable, completely intracorporeal retractors designed for hands-free tissue retraction. The company was founded by David P. Hochman.

Motus G.I. Medical Technologies Ltd. develops a system for diagnosis and treatment of large intestine diseases. The company was founded by Boris Shtul on October 6, 2008 and is headquartered in Tirat Carmel, Israel.

Augment Securities, Inc. (Augment Securities) is a venture capital firm, a subsidiary of Spencer Trask & Co. founded in 1991 by Kevin Brian Kimberlin. The firm is headquartered in New York.

Prescient Medical, Inc. develops diagnostic and therapeutic catheter-based devices for cardiologists. The company was founded by Janet Morrisin, David P. Hochman, Robert A. Lodder and Marvin L. Woodall in 2004 and is headquartered in Doylestown, PA.

Health Dialog Services Corp. provides care management, disease management and analytic services. The firm helps physician groups, health plans and self-insured employers improve healthcare quality while reducing overall costs. The firm's services include analytic services and telephonic and other care management support for individuals. It helps individuals become more actively engaged in their healthcare and have more effective relationships with their physicians. The company was founded by George Bennett and Chris McKown in 1997 and is headquartered in Boston, MA.

Orchestra Medical Ventures LLC (Orchestra Medical Ventures) is a venture capital firm founded in 2001 by Richard P. Geoffrion and Yuval Binur. The firm is headquartered in New Hope, Pennsylvania.

BackBeat Medical, Inc. develops implantable cardiac stimulation devices. It offers devices for the treatment of hypertension. The firm provides apparatus to increase secretion of endogenous natriuretic hormones. The company was founded by Robert A. van Tassel in January 2011 and is headquartered in New Hope, PA.

Vital Access Corp. engages in designing and manufacturing of surgical and interventional technologies. The company was founded by Duane Blatter in July 2006 and is headquartered in Salt Lake City, UT.

Caliber Therapeutics, Inc. is a holding company, which engages in the development of products for atherosclerotic diseases. It offers targeted angioplasty drug delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices. The company was founded on August 3, 2009 and is headquartered in New Hope, PA.

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.